DAFNA Capital Management LLC - PROTEOSTASIS THERAPEUTICS IN ownership

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q4 2018$177,000
-86.1%
54,569
-79.6%
0.09%
-85.7%
Q1 2018$1,269,000
+85.3%
267,100
+127.3%
0.62%
+67.2%
Q4 2017$685,000117,5000.37%
Other shareholders
PROTEOSTASIS THERAPEUTICS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,350,000$36,636,0004.04%
EcoR1 Capital, LLC 602,315$9,390,0002.88%
NEA Management Company, LLC 3,556,778$55,450,0002.49%
Opaleye Management Inc. 152,000$2,370,0001.24%
Avoro Capital Advisors LLC 179,565$2,799,0000.49%
Monashee Investment Management LLC 85,000$1,325,0000.47%
Rock Springs Capital Management LP 450,000$7,016,0000.44%
Perceptive Advisors 344,550$5,372,0000.35%
Hillhouse Capital Management 763,790$11,907,0000.24%
Eventide Asset Management 220,000$3,430,0000.21%
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders